BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8823419)

  • 1. Fludarabine monophosphate as salvage for refractory chronic lymphocytic leukaemia.
    Pillay GS; Wood L; Jacobs P
    S Afr Med J; 1996 Aug; 86(8):949-51. PubMed ID: 8823419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fludarabine monophosphate: a potentially useful agent in chronic lymphocytic leukemia.
    Grever MR; Kopecky KJ; Coltman CA; Files JC; Greenberg BR; Hutton JJ; Talley R; Von Hoff DD; Balcerzak SP
    Nouv Rev Fr Hematol (1978); 1988; 30(5-6):457-9. PubMed ID: 2464793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fludarabine monophosphate in refractory B-chronic lymphocytic leukemia: maintenance may be significant to sustain response.
    Angelopoulou MA; Poziopoulos C; Boussiotis VA; Kontopidou F; Pangalis GA
    Leuk Lymphoma; 1996 Apr; 21(3-4):321-4. PubMed ID: 8726414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fludarabine: a new agent with marked cytoreductive activity in untreated chronic lymphocytic leukemia.
    Keating MJ; Kantarjian H; O'Brien S; Koller C; Talpaz M; Schachner J; Childs CC; Freireich EJ; McCredie KB
    J Clin Oncol; 1991 Jan; 9(1):44-9. PubMed ID: 1702145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fludarabine therapy in chronic lymphocytic leukemia (CLL).
    Keating MJ; Kantarjian H; Talpaz M; Redman J; McCredie KB
    Nouv Rev Fr Hematol (1978); 1988; 30(5-6):461-6. PubMed ID: 2464794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fludarabine phosphate in the treatment of chronic lymphocytic leukemia.
    Keating MJ
    Semin Oncol; 1990 Oct; 17(5 Suppl 8):49-62. PubMed ID: 1699283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Phase II clinical study of SH L 573 (fludarabine phosphate) in patients with chronic lymphocytic leukemia].
    Miyawaki S; Imamura M; Kobayashi S; Ohnishi K; Hodohara K; Mizoguchi H; Tomonaga M; Tango T; Ohno R
    Rinsho Ketsueki; 1999 Dec; 40(12):1236-44. PubMed ID: 10658476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of oral fludarabine phosphate in previously untreated patients with chronic lymphocytic leukemia.
    Rossi JF; van Hoof A; de Boeck K; Johnson SA; Bron D; Foussard C; Lister TA; Berthou C; Kramer MH; Littlewood TJ; Marcus RE; Deconinck E; Montillo M; Guibon O; Tollerfield SM
    J Clin Oncol; 2004 Apr; 22(7):1260-7. PubMed ID: 15051774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of oral fludarabine phosphate in previously treated chronic lymphocytic leukemia.
    Boogaerts MA; Van Hoof A; Catovsky D; Kovacs M; Montillo M; Zinzani PL; Binet JL; Feremans W; Marcus R; Bosch F; Verhoef G; Klein M
    J Clin Oncol; 2001 Nov; 19(22):4252-8. PubMed ID: 11709569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A loading dose/continuous infusion schedule of fludarabine phosphate in chronic lymphocytic leukemia.
    Puccio CA; Mittelman A; Lichtman SM; Silver RT; Budman DR; Ahmed T; Feldman EJ; Coleman M; Arnold PM; Arlin ZA
    J Clin Oncol; 1991 Sep; 9(9):1562-9. PubMed ID: 1714949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New initiatives with fludarabine monophosphate in hematologic malignancies.
    Keating MJ; O'Brien S; Robertson LE; Kantarjian H; Dimopoulos M; McLaughlin P; Cabanillas F; Gregoire V; Yang LY; Gandhi V
    Semin Oncol; 1993 Oct; 20(5 Suppl 7):13-20. PubMed ID: 7694371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients.
    Leporrier M; Chevret S; Cazin B; Boudjerra N; Feugier P; Desablens B; Rapp MJ; Jaubert J; Autrand C; Divine M; Dreyfus B; Maloum K; Travade P; Dighiero G; Binet JL; Chastang C;
    Blood; 2001 Oct; 98(8):2319-25. PubMed ID: 11588025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical experience with fludarabine and its immunosuppressive effects in pretreated chronic lymphocytic leukemias and low-grade lymphomas.
    Fenchel K; Bergmann L; Wijermans P; Engert A; Pralle H; Mitrou PS; Diehl V; Hoelzer D
    Leuk Lymphoma; 1995 Aug; 18(5-6):485-92. PubMed ID: 8528057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose fludarabine and cyclophosphamide in elderly patients with B-cell chronic lymphocytic leukemia refractory to conventional therapy.
    Marotta G; Bigazzi C; Lenoci M; Tozzi M; Bocchia M; Lauria F
    Haematologica; 2000 Dec; 85(12):1268-70. PubMed ID: 11114133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of advanced chronic lymphocytic leukemia by fludarabine. Results of a clinical phase-II study.
    Hiddemann W; Rottmann R; Wörmann B; Thiel A; Essink M; Ottensmeier C; Freund M; Büchner T; van de Loo J
    Ann Hematol; 1991 Jul; 63(1):1-4. PubMed ID: 1715191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of refractory chronic lymphocytic leukemia with fludarabine phosphate via the group C protocol mechanism of the National Cancer Institute: five-year follow-up report.
    Sorensen JM; Vena DA; Fallavollita A; Chun HG; Cheson BD
    J Clin Oncol; 1997 Feb; 15(2):458-65. PubMed ID: 9053466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fludarabine monophosphate in the treatment of patients with advanced stages of chronic B-cell lymphatic leukemia resistant to conventional chemotherapy].
    Papajík T; Faber E; Hubácek J; Slezák P; Raida L; Heczko M; Sulovská I; Jarosová M; Pikalová Z; Indrák K
    Vnitr Lek; 1997 Jan; 43(1):25-8. PubMed ID: 9221561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase I trial of combination fludarabine monophosphate and chlorambucil in chronic lymphocytic leukemia: a Southwest Oncology Group study.
    Elias L; Stock-Novack D; Head DR; Grever MR; Weick JK; Chapman RA; Godwin JE; Metz EN; Appelbaum FR
    Leukemia; 1993 Mar; 7(3):361-5. PubMed ID: 7680398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment with fludarabine of chronic refractory lymphoid leukemia].
    Herrero M; Cabrera JR; Briz M; Forés R; Díez JL; Regidor C; Sanjuán I; Fernández MN
    Sangre (Barc); 1995 Apr; 40(2):115-9. PubMed ID: 7784940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fludarabine treatment in B-cell chronic lymphocytic leukemia: response, toxicity and survival analysis in 47 cases.
    Stelitano C; Morabito F; Kropp MG; Callea V; Iuliano F; Oriana V; Levato D; Nobile F; Molica S; Brugiatelli M
    Haematologica; 1999 Apr; 84(4):317-23. PubMed ID: 10190945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.